Literature DB >> 22815477

Meizothrombin is an unexpectedly zymogen-like variant of thrombin.

Harlan N Bradford1, Sriram Krishnaswamy.   

Abstract

Thrombin is produced by the ordered action of prothrombinase on two cleavage sites in prothrombin. Meizothrombin, a proteinase precursor of thrombin, is a singly cleaved species that accumulates abundantly as an intermediate. We now show that covalent linkage of the N-terminal propiece with the proteinase domain in meizothrombin imbues it with exceptionally zymogen-like character. Meizothrombin exists in a slowly reversible equilibrium between two equally populated states, differing by as much as 140-fold in their affinity for active site-directed ligands. The distribution between the two forms, designated zymogen-like and proteinase-like, is affected by Na(+), thrombomodulin binding, or active site ligation. In rapid kinetic measurements with prothrombinase, we also show that the zymogen-like form is produced following the initial cleavage reaction and slowly equilibrates with the proteinase-like form in a previously unanticipated rate-limiting step before it can be further cleaved to thrombin. The reversible equilibration of meizothrombin between zymogen- and proteinase-like states provides new insights into its ability to selectively exhibit the anticoagulant function of thrombin and the mechanistic basis for its accumulation during prothrombin activation. Our findings also provide unexpected insights into the regulation of proteinase function and how the formation of meizothrombin may yield a long lived intermediate with an important regulatory role in coagulation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22815477      PMCID: PMC3436291          DOI: 10.1074/jbc.M112.394809

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Thrombin.

Authors:  R L Lundblad; H S Kingdon; K G Mann
Journal:  Methods Enzymol       Date:  1976       Impact factor: 1.600

2.  Assembly of the prothrombinase complex enhances the inhibition of bovine factor Xa by tick anticoagulant peptide.

Authors:  S Krishnaswamy; G P Vlasuk; P W Bergum
Journal:  Biochemistry       Date:  1994-06-28       Impact factor: 3.162

3.  Analysis for gamma-carboxyglutamic acid.

Authors:  P A Price
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

Review 4.  The structure of thrombin: a janus-headed proteinase.

Authors:  Wolfram Bode
Journal:  Semin Thromb Hemost       Date:  2006-04       Impact factor: 4.180

5.  Binding of substrate in two conformations to human prothrombinase drives consecutive cleavage at two sites in prothrombin.

Authors:  Steven J Orcutt; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2004-10-19       Impact factor: 5.157

Review 6.  Thrombin interactions.

Authors:  Enrico Di Cera
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

7.  Mechanism by which exosites promote the inhibition of blood coagulation proteases by heparin-activated antithrombin.

Authors:  Gonzalo Izaguirre; Richard Swanson; Srikumar M Raja; Alireza R Rezaie; Steven T Olson
Journal:  J Biol Chem       Date:  2007-09-17       Impact factor: 5.157

8.  Na+ binding to meizothrombin desF1.

Authors:  M E Papaconstantinou; P S Gandhi; Z Chen; A Bah; E Di Cera
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

Review 9.  Serine proteases.

Authors:  Enrico Di Cera
Journal:  IUBMB Life       Date:  2009-05       Impact factor: 3.885

10.  The prothrombinase-catalyzed activation of prothrombin proceeds through the intermediate meizothrombin in an ordered, sequential reaction.

Authors:  S Krishnaswamy; K G Mann; M E Nesheim
Journal:  J Biol Chem       Date:  1986-07-05       Impact factor: 5.157

View more
  9 in total

1.  Occlusion of anion-binding exosite 2 in meizothrombin explains its impaired ability to activate factor V.

Authors:  Harlan N Bradford; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2018-12-21       Impact factor: 5.157

Review 2.  The transition of prothrombin to thrombin.

Authors:  S Krishnaswamy
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

3.  The Fragment 1 Region of Prothrombin Facilitates the Favored Binding of Fragment 12 to Zymogen and Enforces Zymogen-like Character in the Proteinase.

Authors:  Harlan N Bradford; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2016-03-24       Impact factor: 5.157

4.  Ligand binding to anion-binding exosites regulates conformational properties of thrombin.

Authors:  Marina V Malovichko; T Michael Sabo; Muriel C Maurer
Journal:  J Biol Chem       Date:  2013-02-01       Impact factor: 5.157

5.  Membrane binding by prothrombin mediates its constrained presentation to prothrombinase for cleavage.

Authors:  Harlan N Bradford; Steven J Orcutt; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2013-08-12       Impact factor: 5.157

Review 6.  Advances in Clinical and Basic Science of Coagulation: Illustrated abstracts of the 9th Chapel Hill Symposium on Hemostasis.

Authors:  Wolfgang Bergmeier; Silvio Antoniak; Edward M Conway; Cécile V Denis; Lindsey A George; Berend Isermann; Nigel S Key; Sriram Krishnaswamy; Wilbur A Lam; David Lillicrap; Jian Liu; Mark R Looney; José A López; Coen Maas; Flora Peyvandi; Wolfram Ruf; Anil K Sood; Henri H Versteeg; Alisa S Wolberg; Pancras C Wong; Jeremy P Wood; Hartmut Weiler
Journal:  Res Pract Thromb Haemost       Date:  2018-04-12

7.  Crystal structure of the prothrombinase complex from the venom of Pseudonaja textilis.

Authors:  Bernhard C Lechtenberg; Thomas A Murray-Rust; Daniel J D Johnson; Ty E Adams; Sriram Krishnaswamy; Rodney M Camire; James A Huntington
Journal:  Blood       Date:  2013-07-18       Impact factor: 22.113

8.  MASP-1 Induced Clotting--The First Model of Prothrombin Activation by MASP-1.

Authors:  Lorenz Jenny; József Dobó; Péter Gál; Verena Schroeder
Journal:  PLoS One       Date:  2015-12-08       Impact factor: 3.240

9.  Increased Mucosal Thrombin is Associated with Crohn's Disease and Causes Inflammatory Damage through Protease-activated Receptors Activation.

Authors:  Jean-Paul Motta; Simone Palese; Carmine Giorgio; Kevin Chapman; Alexandre Denadai-Souza; Perrine Rousset; David Sagnat; Laura Guiraud; Anissa Edir; Carine Seguy; Laurent Alric; Delphine Bonnet; Barbara Bournet; Louis Buscail; Cyrielle Gilletta; Andre G Buret; John L Wallace; Morley D Hollenberg; Eric Oswald; Elisabetta Barocelli; Sylvie Le Grand; Bruno Le Grand; Celine Deraison; Nathalie Vergnolle
Journal:  J Crohns Colitis       Date:  2021-05-04       Impact factor: 9.071

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.